28
Participants
Start Date
August 31, 2005
Primary Completion Date
August 31, 2010
Study Completion Date
August 31, 2010
metformin
To minimize side effects the metformin will be initiated at 500 mg twice daily with meals and increased to 1 gm twice daily with meals after two weeks and continue to a total of 3 months of dosing.
pioglitazone
To minimize side effects, the pioglitazone will be initiated at 30 mg daily and increased to 45 mg daily after two weeks, and continue to a total of 3 months of dosing.
Placebo
Placebo tablets matching the metformin and pioglitazone tablets are given in the same regimen as the active drug arm for 3 months.
Mayo Clinic, Rochester
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Takeda Pharmaceuticals North America, Inc.
INDUSTRY
National Center for Research Resources (NCRR)
NIH
Mayo Clinic
OTHER